The N-salicyloyltryptamine (NST) is an indole derivative compound analogue to the alkaloid N-benzoyltryptamine. In the present study, the antiedematogenic activity of NST was investigated in animal models. Firstly, the acute toxicity for NST was assessed according to the OECD Guideline no. 423. The potential NST-induced antiedematogenic activity was evaluated by carrageenan-induced paw edema in rats, as well as by dextran-, compound 48/80-, histamine-, serotonin-, capsaicine-, and prostaglandin E2-induced paw edema in mice. The effect of NST on compound 48/80-induced ex vivo mast cell degranulation on mice mesenteric bed was investigated. No death or alteration of behavioral parameters was observed after administration of NST (2000 mg/kg, i.p.) during the observation time of 14 days. The NST (100 and 200 mg/kg, i.p.) inhibited the carrageenan-induced edema from the 1st to the 5th hour (**p<0.01; ***p<0.001). The edematogenic activity induced by dextran, compound 48/80, histamine, serotonin, capsaicin, and prostaglandin E2 was inhibited by NST (100 mg/kg, i.p.) throughout the observation period (**p<0.01; ***p<0.001). The pretreatment with NST (50, 100 or 200 mg/kg, i.p) attenuates the compound 48/80-induced mast cell degranulation (**p<0.01; ***p<0.001). Thus, the inhibition of both mast cell degranulation and release of endogenous mediators are probably involved in the NST-induced antiedematogenic effect.
INTRODUCTION
Inflammation involves the participation of a wide sort of biological mediators, such as histamine, serotonin, bradykinin, and prostaglandins. These inflammatory agents promote vasodilation and neutrophil migration from blood towards inflamed tissues (Hajare et al. 2001) . The interaction between the chemical mediators triggers a sequence of molecular events, and then resulting on the inflammatory process and development of pain (Déciga-Campos et al. 2007) . The inflammatory response is defined as a normal reaction of living tissue to an injured area (Gautam and Jachak 2009) . The lack of the recovery of the injured area increases the damage by formation of granulation tissue and accumulation of secretory cells (enzymes and free radicals), which positively increases the local inflammation, thus impairing the repair of damaged area (Dinarello 2010) .
The drugs commonly used in the treatment of inflammation include the non-steroidal and steroidal anti-inflammatory drugs, which are able to promote several side effects, such as gastric ulcers, dyspepsia, bleeding and cardiovascular disorders (Dinarello 2010 , Narum et al. 2014 . Thus, the discovery of new drugs for the treatment of inflammatory diseases which present good therapeutic efficacy and fewer side effects is strongly necessary.
The indole core structure is part of one of the most natural and synthetic bioactive compounds (Sá-Alves et al. 2009) , with important biological activities (Kaushik 2013) such as anti-inflammatory, antitumoral, analgesic, and antipyretic (Yadav and Romana 2013) . Likewise, there are some indole derivative medicinal compounds usually applied in medical practices, such as: (1) ergometrine, which induces the contraction of the uterine musculature; (2) yohimbine, an alpha-2 adrenergic receptor antagonist; (3) reserpine, whose association with an diuretic is effective in preventing sodium retention and formation of edema (Schripsema et al. 2004) .
Among the indole-based compounds, the benzoyltryptamines are related to the N-benzoyltryptamine named Guillaumin, which was previously isolated from Myrtopsis myrtoidea (Baill.), a plant from the Rutaceae family (Hifnawy et al. 1957) . Other indole derivative compounds with psychotomimetic activity include N,N-dimethyltryptamine and 5-methoxy-N,Ndimethyltryptamine (Jiang et al. 2016 , Shen et al. 2010 and N-salicyloyltryptamine (2-Hydroxy-N-[2-(1H-indol-3-yl)-ethyl]-benzamide ( Fig. 1) , which presents anticonvulsant, hypnotic and muscle relaxant activities (Oliveira et al. 2001) . Furthermore, the N-salicyloyltryptamine (NST) promote an in vitro immunomodulatory response by decreasing the release of inflammatory mediators (Gasparotto et al. 2013 ). However, the in vivo potential of NST for the treatment of inflammatory diseases has not been investigated.
Therefore, the present study aims to investigate the antiedematogenic activity induced by N-salicyloyltryptamine (NST) in animal models of acute inflammation, as well as the possible mechanisms of action.
MATERIALS AND METHODS

ANIMALS
Male and female Wistar rats (180-210 g) and Swiss mice (25-30 g) were obtained from the Animal Facility of the Medicinal Plants Research Center of Federal University of Piauí (Teresina, PI, Brazil). The animals were kept in polypropylene cages, at the controlled temperature of 24±1 °C, light/dark cycles of 12 h, standard food (LabinaPurina®, Nestlé, Brazil) and water ad libitum. For the experimental protocols, the animals were not previously fasted, and then were separated into groups of 6 animals (n=6). After the experimental procedures, the animals were euthanized with Oliveira et al. (2001) . The NST was diluted in 5.0% Tween 80 in saline solution (0.9% NaCl), and administrated at the proportion of 0.1 ml/10 g of body weight.
ACUTE TOXICOLOGICAL EVALUATION IN MICE
The toxicological assessment was performed according to the OECD Guideline no. 423 (OECD 2002) . Female Swiss mice were separated into groups of 3 animals, and then treated with NST at the dose of 2000 mg/kg (i.p.). Afterwards, the animals were submitted to clinical and behavioral observation during 8 hours during the first day of treatment. Afterwards, the animals were daily observed during 2 h in a period of 14 days.
INVESTIGATION OF NST EFFECT ON CARRAGEENAN-INDUCED PAW EDEMA IN RATS
Male and female Wistar rats were separated into five groups (n=6). The animals were intraperitoneally pretreated with vehicle, NST (50, 100, and 200 mg/kg, i.p.) or indomethacin (10 mg/kg). After 30 min, carrageenan (10 mg/mL, 0.1 mL) was administrated in the right hind paw (subplantar region). The thickness of paws were recorded by a digital caliper (Pantec®) at different times (1, 2, 3, 4, 5 and 6 hours) after intraplantar administration of carrageenan. The edema was expressed as the difference between the final thickness (mm) and the initial thickness (mm) of the paw (Winter et al. 1962) . In order to carring out the next protocols of NST-induced antiedematogenic activity, the effective dose of 100 mg/kg was chosen.
INVESTIGATION OF NST EFFECT ON PAW EDEMA INDUCED BY DIFFERENT PHLOGISTIC AGENTS IN MICE
Initially, male and female Swiss mice were divided into 4 groups (n=6), and pretreated (i.p.) with vehicle, NST (100 mg/kg) or indomethacin (10 mg/ kg). After 30 min, 50µL (1.0 mg/mL) of dextran, compound 48/80, histamine, serotonin, capsaicin or prostaglandin E2 was administered in the right hind paw (i.pl.). The Sham group (untreated control group) was intraperitoneally treated with vehicle, and after 30 min, 50 µL of sterile saline was administered by subplantar region. The thickness of paws was recorded by digital caliper (Pantec®) immediately before the administration of phlogistic agents (t 0 ), and each 30 min during 2 h. The edema was expressed as the difference between the final thickness (mm) and the initial thickness (mm) of the paw (Winter et al. 1962) . 
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INVESTIGATION OF NST EFFECT ON THE EX VIVO COMPOUND 48/80-INDUCED MAST CELL DEGRANULATION IN RATS
The animals were divided into 6 groups (n=6), and then intraperitonally treated with vehicle, NST (50, 100 and 200 mg/kg) or ketotifen (2 mg/kg). After 2 h, the animals were euthanized, the mesenteric bed was removed and placed in tubes containing Ringer solution (10 mL). Afterwards, the mast cell degranulation was induced by incubating the mesenteric beds with 100 μL of compound 48/80 (0.4 µg/mL). The Sham group was pretreated with vehicle, and the mesenteric beds were incubated with 100 μL of distilled water instead of compound 48/80. After 30 minutes of incubation, the mesenteric beds were mounted on glass slides and stained with 0.1% toluidine blue. The intact and degranulated mast cells were counted by randomly choosing 10 fields of each slide. The results were expressed as percentage of degranulated mast cells (Norton 1954).
STATISTICAL ANALYSES
The results were expressed as mean ± standard error of the mean (S.E.M.). The One-way ANOVA followed by Tukey's post-test was applied for comparison between groups with only one independent variable, and the Two-way ANOVA followed by Bonferroni post-test between groups with more than one independent variable. The level of significance was considered when * p<0.05. All statistical analyses were performed using Prism® version 6.01 software (GraphPad Software, San Diego, CA, USA).
RESULTS
ACUTE TOXICOLOGICAL ASSESSMENT IN MICE
The NST at the dose of 2000 mg/kg (i.p.) showed neither apparent signal of toxicity nor deaths of the animals after 14 days of observation. Therefore, the DL 50 value was not possible to be determined. (Fig. 3f) . 
DISCUSSION
The indole core structure is present in many natural substances mainly derived from plants (Williams 2001) . The chemical structure of NST consists of an indole core related to the N-benzoyltryptamine, an indole alkaloid isolated from Myrtopsis myrtoidea (Baill) Guillaumin (Hifnawy 1957). Interestingly, reported that several indole derivative compounds are able to promote anti-inflammatory activities in different experimental models of paw edema induced by carrageenan, dextran, and histamine (Barbosa-Filho et al. 2006 ). However, any previous report related to the anti-inflammatory properties of NST was found in experimental models which reproduce an inflammatory response. The paw edema induced by different phlogistic agents represents an experimental model of acute inflammation widely used in order to prospect new drugs with potential application in the treatment of inflammatory diseases (Fernandes et al. 2015) . In this study, NST intraperitoneally administrated inhibited the carrageenan-induced edematogenic effect from the first to fifth hour of observation. These experiments were also performed by the oral route in the carrageenan-induced paw edema, but no anti-edematogenic effect was observed for the NST by this route (data not shown).
The carrageenan-induced inflammatory process involves two phases; the first phase is related to the release of histamine and serotonin from mast cells, while the late phase involves release of prostaglandin, production of cytokines, and intense neutrophil migration (Winter et al. 1962) . During the initial phase of the inflammatory process, the released mediators act on vascular endothelium, and then promote leakage of fluid and proteins towards the inflammatory site (Di Rosa et al. 1971) .
The NST decreased the formation of edema induced by histamine, serotonin, capsaicin and PGE2, suggesting the NST might prevent the release of endogenous mediators responsible for the formation of edema, considering that the inhibition of formation of edema was observed in the dextran-and compound 48/80-induced paw edema throughout the period of observation. These agents are able to induce mast cells degranulation, as well as promote release of vasoactive mediators, such as histamine and serotonin (Metcalfe 2008) .
An antiedematogenic compound which has activity on the experimental paw edema models induced by different phlogistic agent usually acts on the the release of endogenous inflammatory mediators, such as histamine, serotonin, and bradykinin, as well as late mediators, such as inhibition of cyclooxygenase biosynthesis and, consequently, decreased expression of prostaglandins (Sadeghi et al. 2013) . Several substances based on the indole core structure, such as caulerpin, oxepinamide, conicamin, and plakohypaphorine, are able to induce antiedematogenic activity on the paw edema induced by different phlogistic agents (Jaswir and Monsur 2011).
Interestingly, Gasparotto et al. (2013) previously demonstrated that NST inhibits the in vitro LPS-induced release of the inflammation mediators TNF-α e IL-1β. The TNF-α is released by activated macrophages which triggers the proinflammatory cascade, increasing the production of reactive species as well as the expression and release of cytokines. The TNF-α acts synergistically with other cytokines, such as IFN-γ and IL-17, promoting the pro-inflammatory state (Vendramini Costa and Carvalho 2012). In turn, the release of IL-1β by macrophages triggers inflammation and pain-related responses in different cell types. The expression of cyclooxygenase-2 is induced by IL-1β in cells of the central nervous system, which contributes to inflammatory pain hypersensitivity (Neeb et al. 2011) . Thus, it is possible that the antinociceptive effect by NST previously observed (Quintans et al. 2010 ) may be related to the inhibition of IL-1β.
The histamine and serotonin can be present on basophils and platelets, but the mast cells represent their main source, where they can be found in the mast cell granules. The release of these mediators is triggered as response of various stimuli (Sherwood and Toliver-Kinsky 2004) . Therefore, the effect of NST on the compound 48/80-induced ex vivo mast cell degranulation was investigated. The mast cell degranulation occurs probably by a G-protein activation, which leads to the increased of IP3 concentration, whereby the release of intracellular calcium is promoted, resulting in the mast cell degranulation (Costa et al. 1998) . In this study, NST demonstrated a possible membranestabilizing effect in these cells, then inhibiting the degranulation and release of inflammatory mediators.
In conclusion, the present study demonstrated that NST is able to decrease the formation of paw edema induced by different phlogistic agents, and the mast cells degranulation, which represent a sort of relevant experimental models of inflammation widely applied in the investigation of novel natural and synthetic products with therapeutic potential in the treatment of inflammatory diseases. Thus, the inhibition of release or action of mediators might be underlying the NST-induced anti-inflammatory effects. 
